Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Saccharomyces boulardii CNCM I 745 is a unique yeast probiotic discovered in 1923 from tropical fruit skins, used for over 56 years to treat more than 460 million people. It is manufactured at a single site in France using a lyophilisation process, and has proven efficacy in over 100 clinical studies for multiple gastrointestinal disorders including acute diarrhea, antibiotic-associated diarrhea, and Clostridium difficile infection.
Sources
badgut.org shapes more of what AI says about Saccharomyces boulardii than any other source, at 13% of its citations.
els-jbs-prod-cdn.jbs.elsevierhealth.com · gastro.org · health.clevelandclinic.org · intechopen.com
The market map
Probiotic Dietary Supplements →Where AI ranks Saccharomyces boulardii